Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration

被引:15
作者
Palis, Heather [1 ,2 ]
Gan, Wenqi [1 ,3 ]
Xavier, Chloe [1 ]
Desai, Roshni [1 ]
Scow, Marnie [1 ,4 ]
Sedgemore, Kali-Olt [1 ,5 ]
Greiner, Leigh [6 ]
Nicholls, Tonia [2 ,7 ]
Slaunwhite, Amanda [1 ,4 ]
机构
[1] BC Ctr Dis Control, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[3] Univ Connecticut, Dept Publ Hlth Sci, Sch Med, Farmington, CT USA
[4] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[5] Coalit Peers Dismantling Drug War, Vancouver, BC, Canada
[6] BC Correct, Victoria, BC, Canada
[7] BC Mental Hlth & Subst Use Serv, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
DEFICIT HYPERACTIVITY DISORDER; DRUG OVERDOSE; DOUBLE-BLIND; COCAINE-USE; METHYLPHENIDATE; METAANALYSIS; RELEASE;
D O I
10.1001/jamanetworkopen.2022.43653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Studies have suggested a rise in opioid- and stimulant-involved overdoses in recent years in North America. This risk may be acute for individuals who have had contact with the criminal justice system, who are particularly vulnerable to overdose risk. OBJECTIVE To examine the association of opioid and/or stimulant use disorder diagnoses with overdose (fatal and nonfatal) among people with histories of incarceration. DESIGN, SETTING, AND PARTICIPANTS In this cohort study, population-based health and corrections data were retrieved from the British Columbia Provincial Overdose Cohort, which contains a 20% random sample of residents of British Columbia. The analysis included all people in the 20% random sample who had a history of incarceration between January 1, 2010, and December 31, 2014. Outcomes were derived from 5-years of follow-up data (January 1, 2015, to December 31, 2019). Statistical analysis took place from January 2022 to June 2022. EXPOSURES Substance use disorder diagnosis type (ie, opioid use disorder, stimulant use disorder, both, or neither), sociodemographic, health, and incarceration characteristics. MAIN OUTCOMES AND MEASURES Hazard ratios (HRs) are reported from an Andersen-Gill model for recurrent nonfatal overdose events and from a Fine and Gray competing risk model for fatal overdose events. RESULTS The study identified 6816 people (5980 male [87.7%]; 2820 aged <30 years [41.4%)) with histories of incarceration. Of these, 293 (4.3%) had opioid use disorder only, 395 (6.8%) had stimulant use disorder only, and 281 (4.1%) had both diagnoses. During follow-up, 1655 people experienced 4026 overdoses including 3781(93.9%) nonfatal overdoses, and 245 (6.1%) fatal overdoses. In adjusted analyses, the hazard of both fatal (HR, 2.39; 95% CI, 1.48-3.86) and nonfatal (HR, 2.45; 95% CI, 1.94-3.11) overdose was highest in the group with both opioid and stimulant use disorder diagnoses. CONCLUSIONS AND RELEVANCE This cohort study of people with a history of incarceration found an elevated hazard of fatal and nonfatal overdose among people with both opioid and stimulant use disorder diagnoses. This study suggests an urgent need to address the service needs of individuals who have had contact with the criminal justice system and who co-use opioids and stimulants.
引用
收藏
页数:12
相关论文
共 53 条
[1]   COX REGRESSION-MODEL FOR COUNTING-PROCESSES - A LARGE SAMPLE STUDY [J].
ANDERSEN, PK ;
GILL, RD .
ANNALS OF STATISTICS, 1982, 10 (04) :1100-1120
[2]  
[Anonymous], BC COR SERV PAN REV
[3]  
[Anonymous], TREATM STIM US DIS C
[4]   Carvedilol Among Patients With Heart Failure With a Cocaine-Use Disorder [J].
Banerji, Dahlia ;
Alvi, Raza M. ;
Afshar, Maryam ;
Tariq, Noor ;
Rokicki, Adam ;
Mulligan, Connor P. ;
Zhang, Lili ;
Hassan, Malek O. ;
Awadalla, Magid ;
Groarke, John D. ;
Neilan, Tomas G. .
JACC-HEART FAILURE, 2019, 7 (09) :771-778
[5]  
BC Coroners Service, 2021, Illicit Drug Policies
[6]   Reversible delayed posthypoxic leukoencephalopathy after drug overdose: MRI findings in a collection of patients [J].
Aaron M. Betts ;
John L. Ritter ;
Wayne S. Kubal .
Emergency Radiology, 2012, 19 (2) :165-173
[7]   Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial [J].
Blanken, Peter ;
Nuijten, Mascha ;
van den Brink, Wim ;
Hendriks, Vincent M. .
ADDICTION, 2020, 115 (05) :917-923
[8]   Contingency Management for Patients Receiving Medication for Opioid Use Disorder A Systematic Review and Meta-analysis [J].
Bolivar, Hypatia A. ;
Klemperer, Elias M. ;
Coleman, Sulamunn R. M. ;
DeSarno, Michael ;
Skelly, Joan M. ;
Higgins, Stephen T. .
JAMA PSYCHIATRY, 2021, 78 (10) :1092-1102
[9]  
British Columbia Ministry of Health British Columbia Centre on Substance Use, RISK MIT CONT DUAL P
[10]   Management of opioid use disorders: a national clinical practice guideline [J].
Bruneau, Julie ;
Ahamad, Keith ;
Goyer, Marie-Eve ;
Poulin, Ginette ;
Selby, Peter ;
Fischer, Benedikt ;
Wild, T. Cameron ;
Wood, Evan .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (09) :E247-E257